The use of steroids as an adjunct to antimicrobial therapy has been controversial for many decades. Recent reports of the use of steroids in supraphysiological rather than in "industrial" doses in patients with sustained circulatory instability has re-ignited the debate. Anecdotal reports of adrenal insufficiency in septic patients have suggested a relative cortisol deficiency in these patients with poor survival if not given supplementary steroids. The possibility that the hypothalamic pituitary adrenal axis is intimately involved in the pathogenesis of this entity has not previously been highlighted.
Secretory failure of the adrenal glands was first implicated as a factor in the pathogenesis of circulatory collapse in association with infection after the original reports of Waterhouse 1 and Friderichsen 2 . In the early 70s supraphysiological doses of steroids were promoted as adjunct therapy to improve survival in sepsis 3 . However, over the last three decades, the benefits of pharmacological doses of steroids in unselected patients with sepsis have not been supported by large multicentre trials [4] [5] [6] . Moreover, there is evidence that the use of high-dose steroids in sepsis increases morbidity and mortality 7 .
The use of steroid supplementation with infections has a history going back to the days when tuberculosis was prominent 8 . Steroid usage has a well defined place in certain subgroups of septic patients; namely meningitis in infants 9,10 , severe typhoid fever 11 , Pneumocystis carinii pneumonia in AIDS patients 12 , late ARDS 13 , and in patients on chronic steroid therapy or on other drugs known to suppress cortical adrenal function 14 .
In the late 70s and early 80s scattered reports of de novo adrenal insufficiency appeared in the literature suggesting that the prevalence of this condition in critically ill patients could be as high as 40% [15] [16] [17] . The higher incidence probably related to the use of the sedative agent etomidate, which inhibits cortisol production 18 and is now no longer utilized. Others however have suggested that there is a negligible incidence 19, 20 . Whilst absolute adrenal insufficiency is probably uncommon, occult and transient relative adrenal insufficiency is under recognized 21, 22 .
This subsequently led to the evaluation of cortisol levels and response to corticotrophin and predicting survival in septic shock 23, 24 . Whilst basal levels of cortisol correlate with severity of illness, those patients with the highest levels had the worse prognosis [25] [26] [27] [28] . Whilst a single point cortisol value at the onset of septic shock does not correlate with outcome, repeated determinations showing a progressive increase indicate a poor prognosis. A progressive fall of morning cortisol levels has also been observed in the pre-terminal state 16 . It has been suggested that the adrenocorticotrophic hormone (ACTH)/cortisol relationship is intact in survivors 25 , but that this becomes impaired in non-survivors. Confusion in the diagnosis and evaluation of the hypothalamic-pituitary-adrenal (HPA) axis has arisen by reliance on the Short Synacthen Test (SST) and the interpretation of results from this test that was not designed for use in critically ill patients.
Over the last twelve months two separate prospective, randomized, double-blind, placebo-controlled studies have confirmed the usefulness of moderate doses of glucocorticoids during septic shock 29, 30 .
No one has been able to suggest what the appropriate "stress" levels of cortisol in patients with septic shock are, or what might be the mechanism of occult steroid deficiency. It is therefore timely to review the current status of this complex issue and discuss the possible pathogenesis, limitations of previous diagnostic evaluation and clinical situations where cortisol supplementation might be useful .
HYPOTHALAMIC-PITUITARY-ADRENAL AXIS (HPA) IN SEPSIS
The HPA axis and the sympathetic nervous system are the peripheral limbs of the stress response. Activation of this stress response causes corticotrophin-releasing hormone (CRH) induced secretion of pro-opiomelanacortin-derived and other opioid peptides, which enhance analgesia. These peptides simultaneously inhibit the stress response by suppressing the secretion of CRH and sympathetic hormones. CRH also stimulates the secretion of corticotrophin (ACTH), which is the key regulator of glucocorticoid secretion from the adrenal cortex.
After surgery or trauma, the normal circadian variation in ACTH and cortisol release is lost and may not return for a number of days 31 (Figure 1 ).
Activation of the inflammatory response from infective or non-infective causes leads to the increase in circulating cytokines that also have a profound direct stimulation of the HPA 34 . The proinflammatory cytokines, tumor necrosis factor α, interleukin-1 (IL-1) and interleukin-6 (IL-6) account for most of the HPA axis stimulation Each of these cytokines shows a positive feedback loop. TNF-α, and IL-1 stimulate each other and both stimulate IL-6. IL-6 inhibits the secretion of the other two cytokines in turn. IL-6 is thus both a pro-and an antiinflammatory cytokine.
The three inflammatory cytokines stimulate the HPA axis independently but together act synergistically. IL-6 seems to be one of the most potent stimuli of the HPA axis 35 (Figure 2 ). Subcutaneous IL-6 administration to humans results in elevated ACTH levels followed by a rise in cortisol levels 36 . This suggests that the cortisol response to IL-6 is mediated by the release of ACTH.
Furthermore, the plasma concentrations of ACTH and cortisol resulting from IL-6 stimulation are well in excess of those concentrations achievable from maximal stimulation doses of CRH. It also seems that IL-6 may stimulate other secretagogues such as vasopressin (AVP) 37 .
The HPA axis in critical illness is not under the normal physiological feedback control as has been recently stressed 38 . The critically ill patients in this 156 B. U. IHLE Anaesthesia and Intensive Care, Vol. 29, No. 2, April 2001 FIGURE 1: Mean daily serum cortisol concentrations in18 consecutive septic patients, 12 postoperative multi-trauma patients. Note the septic patients tended to have even higher levels. To convert to nanomoles per liter, multiply by 27.6 32, 33 .
u Patients with severe sepsis s Patients with multiple trauma * Normal subjects study had a markedly impaired suppression of plasma ACTH and cortisol with dexamethasone demonstrating an altered glucocorticoid feedback. Also, despite elevated baseline cortisol concentrations, stimulation with CRH resulted in significantly higher peak ACTH concentrations 15 minutes after CRH than in controls. Similarly cortisol levels peaked at higher levels than controls suggesting that hypersecretion of CRH-like activity (vasopressin or cytokines) occurs in critically ill patients. Thus continuous and sustained ACTH secretion might be occurring in these patients despite sustained elevated circulating cortisol levels. Continuous ACTH secretion may lead to depletion over a period of time if the primary stimulus is sustained. This in turn would result in either absolute or relative cortisol deficiency. Sustained stimulation of HPA axis by IL-6 would exacerbate this even further.
Another recently identified peptide is involved in HPA axis control during severe stress. Animal and human studies have suggested that leptin secretion is closely linked to the functions of the HPA axis and the immune system 39 . Leptin is produced by adipocytes. This hormone inhibits appetite and stimulates the sympathetic nervous system. In healthy controls, plasma leptin and cortisol levels have reciprocal circadian rhythms with high nocturnal leptin levels (peak at 2300 hours) and low nocturnal cortisol concentration In critically ill patients this relation is abolished 40 . Measuring leptin, ACTH, IL-6 and plasma cortisol levels in patients fulfilling the criteria for sepsis, the mean plasma leptin levels were threefold higher in critically ill patients compared to controls. Similarly, ACTH levels were lower in patients than in controls, while plasma cortisol levels were markedly elevated in all patients with sepsis compared to controls. Morning IL-6 levels were markedly elevated in all patients compared to controls. Mean leptin levels were threefold higher in patients who survived the septic episode than in non-survivors.
The same authors further explored the relationship of leptin and IL-6 in regard to survival 41 . Leptin is known to inhibit the HPA axis whereas IL-6 stimulates ACTH release. To examine this question, samples of leptin, IL-6 and cortisol were taken every four hours in eight patients on day 1 of ICU admission for acute sepsis and repeated on days 3 and 5 in the five survivors. The levels of all three hormones were markedly elevated with a lack of normal diurnal rhythmicity of leptin as previously described. A strong negative correlation between 24 hour IL-6 and leptin was shown. Although such a relationship could be explained by the negative and positive effects of cortisol hypersecretion on each hormone respectively, in fact a negative correlation between leptin and cortisol was detected, and there was no significant correlation between IL-6 and cortisol. Mean IL-6 values were higher and leptin lower in non-survivors compared to survivors. These findings suggest that IL-6 is not the principal stimulus of leptin hypersecretion in septic patients. The negative correlation between IL-6 and leptin is of potential importance, as high IL-6 levels have been associated with poor outcome. Unfortunately, ACTH levels were not shown in this study, as falling or low levels in non-survivors might indicate continuous ACTH stimulation and eventual pituitary depletion.
Decreased ACTH secretion leading to adrenal insufficiency has been suggested by other investigators possibly as a result of sustained levels of IL-64 2 . In this study of 21 patients admitted with septic shock, five exhibited adrenal insufficiency within 24 hours of the diagnosis of septic shock. In all five cases, ACTH levels were inappropriately low and not statistically different from normal. Of interest was that IL-6 levels were on an average 40 times greater than normal. Our unpublished experience and that of others 43 is that adrenal insufficiency (secondary, not primary) develops over a period of time and an inability to wean off inotropic agents requires adrenal insufficiency to be excluded.
Further complexity to the regulatory mechanisms of the HPA axis in critically ill patients has been highlighted by a study from The Netherlands 32 . These investigators measured ACTH, cortisol, endothelin-1 (Eti), and atrial natriuretic hormone (ANHi) in 18 patients with clinically defined sepsis and compared levels with 18 trauma and 15 hospital patients without an acute illness. Daily samples were taken for a total of eight consecutive days. Cortisol levels remained high during the whole observation period in the critically ill patients. In contrast, ACTH levels decreased between days 3 and 5, reaching significantly lower levels on day 5 compared to controls and remained low. Plasma levels of Eti and ANHi were significantly elevated throughout the period compared to controls. The high plasma concentration of Eti may stimulate adrenal cortical secretion directly or potentiate the effect of ACTH. The previous studies mentioned above negate the possible negative feedback of ACTH by cortisol. The high ANHi levels however may be another potential inhibitor to ACTH release. This adds further evidence to potential secondary adrenal insufficiency by way of either ACTH inhibition or pituitary ACTH depletion from sustained stimulation.
Two other recently published studies add further evidence to the interaction of the inflammatory process and the HPA axis. In the first one, incubation of anterior pituitary cells in tissue culture in the presence of TNF-α led to inhibition of ACTH release to CRF stimulation 44 . This was a dose-dependent effect and reversible when incubation took place in the presence of a TNF-α antibody. Furthermore, other anterior pituitary hormones showed a similar response to their respective hypothalamic releasing factor.
A human model demonstrating a similar relationship has been documented in African trypanosomiasis, where in the presence of elevated serum TNF-α and IL-6 levels there is a blunted response of ACTH and cortisol concentrations to an injection of CRH. Following appropriate therapy for this infection, the response returns to normal 45 .
In summary, in patients with a sustained inflammatory response, a complex interaction occurs with an initial sustained elevation in cortisol and ACTH secretion. The normal circadian rhythm is lost as well as the negative feedback control. After four to five days a marked fall to below normal physiological levels of ACTH occurs, whilst cortisol levels remain high. A complex interaction of cytokines, vasopressin, atrial naturetic peptide, endothelin, leptin and probably other compounds involved in the inflammatory process, e.g., prostanoids, may be involved. Whether this is all mere correlation or cause and effect remains to be determined. Most of the previously mentioned studies do not define clearly the time course in relation to the illness and future studies will need to consider time dependent variables in evaluating these "hormone" interactions.
PLACE OF SHORT SYNACTHEN TEST (SST) IN CRITICAL ILLNESS
The rapid corticotropin stimulation test has been suggested to be useful in evaluating adrenocortical function. However, quite variable responses can be obtained, with increased basal cortisol levels showing little or no increment to ACTH injection 46 . Other patients may continue to respond with even higher cortisol levels with ACTH. The criteria for a normal response to the SST were established in healthy patients and in patients with absolute adrenal insufficiency 47 . It is unclear whether these criteria can be applied in patients with septic shock, as a poor response may indicate maximal stimulation or alternatively a low basal cortisol level that does not increase appropriately may relate to an involuted, i.e., a prolonged under-stimulated adrenal gland 48 .
From the above discussion, the adrenal insufficiency in septic patients seems to be a secondary failure, i.e., lack of ACTH. Depending on the time course, adrenal atrophy will occur with loss of stimulation. The danger with the use of a SST in a relative acute ACTH deficiency is that a normal response will occur, with a peak response of 550 nmol/l and patients will be denied the appropriate steroid replacement. High agonal cortisol levels have also been shown to result from reduced hepatic clearance 49 . From serial measurements of cortisol in septic shock patients, the number of secretory peaks and the amplitudes of the peaks are reduced when compared with healthy controls 50 . This may indicate a diminished contribution of secretory pulses to the total level of cortisol.
The combined results of nine studies, comparing the SST to "gold standard" of secondary adrenal insufficiency-insulin-induced hypoglycaemia, as well as with overnight metyrapone test, or glucagon stimulation test, indicate that 40 to 45% of patients with secondary adrenal insufficiency are capable of a "normal" response to the SST. Therefore it has been proposed that this test has no place in evaluating this type of adrenal insufficiency, as serious and potentially fatal consequences may result in those critically ill patients with ACTH deficiency who are denied glucocorticoids 48 .
What should be the correct diagnostic approach if secondary adrenal insufficiency is suspected? Obviously insulin-induced hypoglycaemia is inappropriate in the ICU situation.
The critically ill patient whose circulatory status is requiring inotrope therapy and has manifestations of SIRS and is not improving despite appropriate antibiotics or treatment of the primary cause of the SIRS, should have a simultaneous plasma cortisol and ACTH concentration evaluated. As the latter test result is usually delayed, replacement therapy should commence immediately to supraphysiological levels. Results of cortisol levels can usually be obtained within 48 hours at which time the cessation or continuation of steroid therapy can be considered. Similarly a high fever with persistent negative microbiological cultures not responding to antibiotic therapy should have similar evaluation. As adrenal insufficiency is a developing condition, these signs may pre-date circulatory problems. Laboratory abnormalities that should raise suspicion are hypoglycaemia, hyponatraemia, hyperkalaemia, neutropenia and eosinophilia.
Over the last 17 months we have evaluated the SST in our patients who might have adrenal insufficiency. In 13 patients who clinically had evidence of circulatory collapse in the context of SIRS from either septic or nonseptic causes (e.g., pancreatitis), the baseline cortisol concentrations ranged from 99 to 583 nmol/litre (mean 325±29.3 nmol/litre SEM). The 30-minute cortisol concentrations rose to an average of 498±44.2 nmol/litre and the 60-minute to an average value of just 501±45.9 nmol/litre. Only four patients increased their cortisol levels to above 550 nmol/litre (Table 1) .
Of greater interest were the base line ACTH levels in those patients where it was measured appropriately (n=13). Eleven patients had an ACTH concentration of <3.0 pmol/litre. The others ranged from 4.4 to 8.8 pmol/litre. These are well below the values obtained in one patient with cardiogenic shock, (random ACTH 20 pmol/litre and concurrent cortisol of 1688 nmol/litre) and a patient with faecal peritonitis who on day one had an ACTH of 50 pmol/litre and simultaneous cortisol concentration of 1820 nmol/litre.
In two patients the SST was repeated after a 10-day interval and with continuing circulatory com-promise. In both patients the baseline ACTH and cortisol levels fell. The ACTH fell from 18 to 8.8 and 6.9 to <3.0 pmol/litre and the cortisol from 590 to 389 and 449 to 99 nmol/litre.
In one patient who had an inadequate SST response (ACTH <3.0 pmol/litre and cortisol 321 to 403 nmol/litre after 60 minutes) on day 28 of severe ongoing pancreatitis and inotropic requirements, it was demonstrated that adrenal stimulation was still possible by way of a 48 hour ACTH stimulation. The cortisol concentration increased from 367 nmol/litre to 821 nmol/litre. In a repeat SST, after 10 days of hydrocortisone infusion and resolution of the inflammatory process, the cortisol concentration increased from 448 to 1268 nmol/litre.
These anecdotal case studies suggest that secondary adrenal insufficiency develops over time as a result of the inflammatory process continuing unabated. The adrenal cortex is however still capable of responding to ACTH. This however is unable to be adequately tested for with the SST. After the stimulus to the inflammatory process has been eradicated (and the patient survives), the normal HPA axis recovers and this can be assessed by way of the SST.
REPLACEMENT OF PHYSIOLOGICAL STRESS LEVELS OF CORTISONE
In the critically ill patient with a sustained inflammatory response from either a septic or non-septic cause, cortisol deficiency might lead to circulatory collapse requiring either increasing or continuing inotropic support. Glucocorticoids at appropriate levels are necessary to protect the host from overreaction and continuing development of multi-organ dysfunction. This is achieved mainly by suppression of cytokine production via a decreased transcription for pro-inflammatory cytokines and an increased transcription for IL-1 receptor antagonists. In addition, glucocorticoids decrease inducible cyclooxygenase as well as preventing the release of adhesion molecules (ICAM-1, VCAM-1) 51 .
During prolonged septic shock both beta-and alpha-receptors are desensitized to circulating catecholamines 52 through the action of various cytokines. It has been suggested that glucocorticoids are important in restoring the sensitivity of these receptors. Corticosteroids increase the expression of IkBa, a protein that traps and inactivates nuclear factor kappa B (NFkB). This latter protein is an activator of cytokine genes and mediator of the pro-inflammatory cytokine TNF. Inhibition of NFkB also blocks the inducible nitric oxide synthase enzyme 53, 54 .
The appropriate concentrations of cortisol in sepsis and septic shock are unknown. The open nonrandomized studies of the use of high physiological doses of steroids in late septic shock have shown improved haemodynamics with an increase in blood pressure and discontinuation of vasopressors [55] [56] [57] . More recently a prospective, double-blind, randomized, placebo-controlled study in 41 late septic shock patients showed a greater reversal of shock at 7 and 28 days (68% versus 21%; P=0.007) and an improved 28 day survival (63% versus 32%; P=0.091) in the steroid treated group compared to the placebo treated group 29 . Although the authors state that there was similar rate of shock reversal in responders and non-responders to a Short Synacthen Test (SST), the treated group had lower cortisol concentrations and the placebo group had twice as many non-responders to SST. Further, the population studied was not representative of general septic patients as they excluded patients with severe sepsis and early septic shock. In other words, patients who died within 48 hours were excluded as the target population. Thus there were probably time-dependent metabolic and/or hormonal changes that influenced the results.
A very recent similar study utilizing "stress" hydrocortisone doses 30 in septic shock patients showed a reduction in time of shock reversal, decrease in the number of organ system failures and decline in the number of ventilator associated ICU days. The overall incidence of shock reversal and survival however was not different in the two groups, although trends emerged and a type 2 error could be responsible. This study also differed from the previous one in the duration of steroid use as well as the continuous versus intermittent administration. The authors suggest that the continuous infusions at the dose administered exert a mineralocorticoid effect, which might enhance the vasopressor response.
The question frequently asked is why do these supraphysiological doses work whilst pharmacological doses have failed in the past. The answer may be partly related to the fact that the recent studies were performed in only one or two units whilst the others were multicentre and very heterogeneous in term of the case mix as well as therapy, particularly antibiotics. Further, previous mega dose studies used no clear definition of sepsis or septic shock as defined by the American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference 58 .
The dose of methylprednisolone administered was for one to four doses and given early rather than late in the course of the illness. The concurrent use of vasopressor therapy was not a criterion evaluated in the multicentre studies. In two meta-analyses of the effects of steroids in patients with sepsis or septic shock, only 9 of 49 and 10 of 124 studies were considered of sufficient methodological quality to be included 5, 6 . The meta-analyses did not address the timing of the therapy because of the lack of information in the published trials.
In the two clinical trials with the best methodological quality scores 4,7 , patients with gram-negative sepsis responded better to steroid therapy than patients with other infections. This slight advantage was outweighed by a higher mortality among steroid treated patients with gram-positive sepsis.
The negative effects of high-dose steroid therapy are however generally ascribed to the profound immune-suppression so that the overall effect is either neutral or even deleterious 5 .
CONCLUSION
The prevalence of cortisol deficiency, either absolute or relative, is unlikely to have altered over the last decade or so. However the recognition of this pathological phenomenon has certainly increased. Despite this, the diagnostic criteria are confusing, with the greatest attention being focused on adrenal unresponsiveness by utilizing the SST.
It seems that some of the pieces of the jigsaw puzzle are starting to align themselves, although the overall pathophysiology is complex and probably multifactorial. The evidence suggests that this condition develops as a result of the sustained inflammatory response from either infective or non-infective source. This in turn leads to a cytokine (or other hormonal) secretory stimulation or suppression of the hypothalamic-pituitary-axis. This "bi-directional communication", as described by Blalock, between the immune and endocrine system functions acts as a defence mechanism in the initial stages of SIRS but if sustained over a period of days or as a result of repeated stimulation may lead to circulatory collapse as result of inability to sustain appropriate levels of hydrocortisone. The primary failure is therefore the loss of ACTH secretion and not primary adrenal insufficiency.
The SST is confusing and difficult to interpret in these situations. No strict criteria for relative adrenal insufficiency are currently available. Further, testing the adrenocortical function as a prognostic factor in ICU patients as has been suggested in a number of studies, I believe is of no value. Simultaneously collected cortisol and ACTH levels would be more useful prior to the commencement of hydrocortisone replacement. In this way, it might be possible to answer the question whether cortisone in supraphysiological levels is more effective in the low (normal) cortisol/low ACTH group or the normal (high)/high ACTH group or both. Even when low levels are not confirmed, there may be a group of patients who will respond to higher "stress" hydrocortisone levels by diminishing or eliminating the need for vasopressors. Typically, these patients present with the haemodynamic features of systemic inflammatory response syndrome are unresponsive to inotrope therapy and are at least five to seven days into their illness. The features including fever may all relate to adrenal insufficiency and will only correct with supplemental steroid therapy. In addition there are a group of patients who have genetically based variations in levels of stress induced cortisol levels 59 . The cortisol concentration that is appropriate in these situations is unknown and most likely variable from patient to patient. Future research will need to concentrate on the time course of development of this condition. Daily cytokine levels as well as leptin or other identifiable stimuli or inhibitors of the HPA axis in the appropriate clinical situation together with ACTH and cortisol levels might help elucidate this clinical phenomenon.
